These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 23031625

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
    Kelton CM, Chang LV, Guo JJ, Yu Y, Berry EA, Bian B, Heaton PC.
    Appl Health Econ Health Policy; 2014 Apr; 12(2):165-77. PubMed ID: 24550087
    [Abstract] [Full Text] [Related]

  • 5. Forecasting Medicaid Expenditures for Antipsychotic Medications.
    Slade EP, Simoni-Wastila L.
    Psychiatr Serv; 2015 Jul; 66(7):713-8. PubMed ID: 25828875
    [Abstract] [Full Text] [Related]

  • 6. Opioid expenditures and utilization in the Medicaid system.
    Brixner DI, Oderda GM, Roland CL, Rublee DA.
    J Pain Palliat Care Pharmacother; 2006 Jul; 20(1):5-13. PubMed ID: 16687350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM, Silverman HA.
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changing strategies for the management of invasive fungal infections.
    Rapp RP.
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA, Polinski JM, Choudhry NK, Avorn J, Fischer MA.
    BMC Health Serv Res; 2016 Jan 15; 16():15. PubMed ID: 26772962
    [Abstract] [Full Text] [Related]

  • 15. Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.
    Chiu SF, Kelton CM, Guo JJ, Wigle PR, Lin AC, Szeinbach SL.
    Am Health Drug Benefits; 2011 May 15; 4(3):140-9. PubMed ID: 25126346
    [Abstract] [Full Text] [Related]

  • 16. The cost effect of newer medication adoption in an older Medicaid cohort.
    Shireman TI, Rigler SK, Jachna CM, Griebling TL, Eng ML.
    J Am Geriatr Soc; 2005 Aug 15; 53(8):1366-73. PubMed ID: 16078963
    [Abstract] [Full Text] [Related]

  • 17. Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021.
    Shin YE, Kumar A, Guo JJ.
    Clin Drug Investig; 2023 Apr 15; 43(4):289-298. PubMed ID: 37005969
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017.
    Bartlett VL, Liu P, Dhruva SS, Shah ND, Bollinger KE, Ross JS.
    J Manag Care Spec Pharm; 2020 Apr 15; 26(4):562-567. PubMed ID: 32223594
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.